Literature DB >> 2832088

Varicella-zoster virus infection and immunization in the healthy and the immunocompromised host.

C Grose1, R H Giller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832088     DOI: 10.1016/s1040-8428(88)80004-0

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  6 in total

1.  Calculation of the anterograde velocity of varicella-zoster virions in a human sciatic nerve during shingles.

Authors:  Raymond Tannous; Charles Grose
Journal:  J Infect Dis       Date:  2010-12-24       Impact factor: 5.226

2.  T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV.

Authors:  A R Hayward
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

Review 3.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

4.  Severe Herpes Zoster Following Varicella Vaccination in Immunocompetent Young Children.

Authors:  Amaran Moodley; Jack Swanson; Charles Grose; Daniel J Bonthius
Journal:  J Child Neurol       Date:  2019-01-10       Impact factor: 1.987

5.  The round trip model for severe herpes zoster caused by live attenuated varicella vaccine virus.

Authors:  Charles Grose; Lynn W Enquist
Journal:  J Med Virol       Date:  2020-01-17       Impact factor: 2.327

Review 6.  Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus.

Authors:  Ethan H Heusel; Charles Grose
Journal:  Viruses       Date:  2020-09-25       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.